Analytical ultracentrifuge with absorbance and interference optics.
具有吸光度和干涉光学器件的分析超速离心机。
基本信息
- 批准号:10177341
- 负责人:
- 金额:$ 38.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAreaAutophagocytosisBiological ProcessBiophysicsCell surfaceCharacteristicsCollaborationsCore FacilityDoctor of PhilosophyEnzymesFacultyFee-for-Service PlansFeesFundingGPR3 geneGTP-Binding Protein alpha Subunits, GsHeterogeneityLipidsLongevityMaintenanceModelingMolecular ConformationNorth DakotaOpticsPharmacologyProductivityRadialRegulationResearchResearch PersonnelSamplingScientistShapesSignal TransductionSupervisionTimeUnited States National Institutes of HealthUniversitiesWagescollegeheme ainstrumentinstrumentationmacromoleculeprotein protein interactionservice providersstudent trainingsugartraining opportunity
项目摘要
PROJECT SUMMARY/ABSTRACT
Funds to purchase an Analytical Ultracentrifuge (AUC), model Beckman Couture Optima AUC, are
being requested. This state-of-the-art instrument will expand the research capabilities of a core number of NIH
funded investigators at North Dakota State University (NDSU). The AUC will allow characterization of
macromolecules in solution to obtain quantitative details on the size, shape, heterogeneity, conformation, and
assembly dynamics of these samples. This biophysical information provides critical information to understand
the activation, inhibition, overall regulation, and general function of biological processes. The chosen
instrument has both interference and absorbance optics allowing for the characterization of a broad range of
sample types, including sugars and lipids that do not have characteristic absorbance coefficients. Currently,
NDSU does not have this instrumentation and there is no AUC within a 200 mile radius. Therefore, users are
currently relying on access to an AUC via long distance collaboration or for fee service providers. This can be
inefficient and/or prohibitively expensive for investigators. The instrument will be housed in a core facility
managed by a full time Ph.D. scientist, supported by NDSU and whose salary is not dependent on user fees.
Thus, access and maintenance of the instrument will have direct supervision protecting the longevity of the
instrument. Projects of immediate relevance that will be addressed involve 1) protein:protein interactions
involved in bacterial cell surface signaling, 2) understanding agonist/antagonist influence on protein:protein
interactions involve in a G-protein coupled receptor, 3) protein:protein interactions involved in autophagy
regulation, and 4) assembly dynamics of a heme utilizing enzyme. Overall, our user group represents
investigators in four departments across three colleges and the instrument will facilitate research in areas
related to pharmacology to materials. The presence of an AUC at NDSU will greatly enhance the research
directions of these and other projects of NIH relevance. It will significantly increase student training
opportunities and research productivity of faculty.
项目总结/摘要
购买Beckman Couture Optima AUC型分析型超浓缩浓缩机(AUC)的资金如下:
被要求。这种最先进的仪器将扩大NIH核心研究能力
北达科他州州立大学(NDSU)资助的调查人员。AUC将允许表征
在溶液中的大分子,以获得定量的细节的大小,形状,异质性,构象,
这些样品的组装动力学。这些生物物理信息提供了重要的信息,
生物过程的激活、抑制、整体调节和一般功能。所选择的
仪器具有干涉和吸收光学器件,允许表征宽范围的
样品类型,包括不具有特征吸收系数的糖和脂质。目前,
NDSU没有这种仪器,在200英里半径内没有AUC。因此,用户
目前依赖于通过远程协作或付费服务提供商访问AUC。这可以
效率低和/或昂贵得令人望而却步。该仪器将被安置在一个核心设施中,
由一位全职博士管理科学家,由国家发展科学研究所资助,其工资不依赖于使用费。
因此,仪器的访问和维护将受到直接监督,
仪器将被解决的直接相关的项目涉及1)蛋白质:蛋白质相互作用
参与细菌细胞表面信号传导,2)了解激动剂/拮抗剂对蛋白质的影响:蛋白质
G蛋白偶联受体中的相互作用,3)自噬中的蛋白质:蛋白质相互作用
调节,以及4)血红素利用酶的组装动力学。总的来说,我们的用户群代表了
调查人员在四个部门跨越三个学院和仪器将促进研究领域
与药理学和材料有关的。在国防科学研究所设立一个非盟委员会将大大加强研究工作,
这些项目和其他NIH相关项目的方向。它将大大增加学生的培训
机会和教师的研究生产力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher L Colbert其他文献
Christopher L Colbert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher L Colbert', 18)}}的其他基金
Structural basis for cell surface siganling by a Gram-negative bacteria sigma-regulator
革兰氏阴性菌西格玛调节器细胞表面信号的结构基础
- 批准号:
9789675 - 财政年份:2018
- 资助金额:
$ 38.44万 - 项目类别:
Structural basis for cell surface siganling by a Gram-negative bacteria sigma-regulator
革兰氏阴性菌西格玛调节器细胞表面信号的结构基础
- 批准号:
10004679 - 财政年份:2018
- 资助金额:
$ 38.44万 - 项目类别:
Structural basis for cell surface siganling by a Gram-negative bacteria sigma-regulator
革兰氏阴性菌西格玛调节器细胞表面信号的结构基础
- 批准号:
10387865 - 财政年份:2018
- 资助金额:
$ 38.44万 - 项目类别:
Structural basis for cell surface siganling by a Gram-negative bacteria sigma-regulator
革兰氏阴性菌西格玛调节器细胞表面信号的结构基础
- 批准号:
10240569 - 财政年份:2018
- 资助金额:
$ 38.44万 - 项目类别:
Mechanism of inner membrane sigma-regulator function in Gram-negative bacteria
革兰氏阴性菌内膜西格玛调节功能的机制
- 批准号:
9316212 - 财政年份:2015
- 资助金额:
$ 38.44万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 38.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 38.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




